Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F V Lewis

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Current Medicinal Chemistry|July 23, 2003
Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 familiesDavid F V Lewis
Journal of Inorganic Biochemistry|September 19, 2002
Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic templateDavid F V Lewis
Archives of Biochemistry and Biophysics|December 5, 2002
Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymesDavid F V Lewis
Drug Metabolism Reviews|May 9, 2002
Molecular modeling of human cytochrome P450-substrate interactionsDavid F V Lewis
Thescientificworldjournal|July 9, 2003
Structural models for cytochrome P450-mediated catalysisDavid F V Lewis
Pharmacogenomics|July 2, 2003
P450 structures and oxidative metabolism of xenobioticsDavid F V Lewis
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactionsDavid F V Lewis
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 25, 2003
Quantitative structure-activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymesDavid F V Lewis
Thescientificworldjournal|January 6, 2005
Hydrogen bonding in human p450-substrate interactions: a major contribution to binding affinityDavid F V Lewis
Pharmacogenomics|April 23, 2004
57 varieties: the human cytochromes P450David F V Lewis
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Current Medicinal Chemistry|July 23, 2003
Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 familiesDavid F V Lewis
Journal of Inorganic Biochemistry|September 19, 2002
Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic templateDavid F V Lewis
Archives of Biochemistry and Biophysics|December 5, 2002
Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymesDavid F V Lewis
Drug Metabolism Reviews|May 9, 2002
Molecular modeling of human cytochrome P450-substrate interactionsDavid F V Lewis
Thescientificworldjournal|July 9, 2003
Structural models for cytochrome P450-mediated catalysisDavid F V Lewis
Pharmacogenomics|July 2, 2003
P450 structures and oxidative metabolism of xenobioticsDavid F V Lewis
Expert Opinion on Drug Metabolism & Toxicology|August 23, 2006
Human P450s in the metabolism of drugs: molecular modelling of enzyme-substrate interactionsDavid F V Lewis
Toxicology in Vitro : an International Journal Published in Association with BIBRA|November 25, 2003
Quantitative structure-activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymesDavid F V Lewis
Thescientificworldjournal|January 6, 2005
Hydrogen bonding in human p450-substrate interactions: a major contribution to binding affinityDavid F V Lewis
Pharmacogenomics|April 23, 2004
57 varieties: the human cytochromes P450David F V Lewis
Pageof 6